特徴
- 主な研究分野例：Cancer, Epigenetics and Nuclear Signaling, Signal Transduction
- 背景：The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. This protein also acts as a metastasis suppressor. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene.
仕様
- サイズ：20uL
- 抗体タイプ：Polyclonal Antibody
- アプリケーション：IHC,ELISA
- 交差性：Human, Mouse, Rat
- 宿主：Rabbit
- アイソタイプ：IgG
- 濃度：1.2 mg/mL
- 抗原：Synthetic peptide of human MED23
- 緩衝液：PBS with 0.05% NaN3 and 40% Glycerol,pH7.4
- 精製方法：Antigen affinity purification
- 希釈倍率：IHC 1:30-1:150, ELISA 1:5000-1:10000
- 標識：Unconjugated
- クローナリティ：Polyclonal
- メーカーマニュアルリンク：https://www.elabscience.com/viewpdf-253868-Elabscience-E-AB-17863.pdf
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
商品のバリエーション （サイズ違い・スペック違い・オプション品など）
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
89-7838-48
MED23 Polyclonal Antibody 200uL
|
|
|
89-7838-45
MED23 Polyclonal Antibody 20uL
|
|
|
89-7838-47
MED23 Polyclonal Antibody 120uL
|
|
|
89-7838-46
MED23 Polyclonal Antibody 60uL
|
よくあるご質問（FAQ）
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|